High baseline serum levels of interleukin-23 can help to identify hepatitis B e antigen-positive chronic hepatitis B patients who are likely to respond to pegylated interferon treatment, a Chinese study indicates.
from The Medical News http://ift.tt/1vHe8vM
from The Medical News http://ift.tt/1vHe8vM
No comments:
Post a Comment